Structure-Based Design of Substituted Diphenyl Sulfones and Sulfoxides as Lipophilic Inhibitors of Thymidylate Synthase
Received August 26, 1996 Abstract: Six new diphenyl sulfoxide and five new diphenyl sulfones were
designed, synthesized, and
tested for their inhibition of human and Escherichia coli
thymidylate synthase (TS) and of the
growth of cells in tissue culture. The best sulfoxide inhibitor of
human TS was 3-chloro-N-((3,4-dihydro-2-methyl-4-oxo-6-quinazolinyl)methyl)-4-(phenylsulfinyl)-N-(prop-2-ynyl)aniline (7c) that had a Ki of 27 nM.
No sulfone improved on TS inhibition by the
previously
reported
4-(N-((3,4-dihydro-2-methyl-6-quinazolinyl)methyl)-N-prop-2-ynylamino)phenyl
phenyl
sulfone (Ki = 12 nM). Nevertheless, one
sulfone,
4-((2-chlorophenyl)sulfonyl)-N-((3,4-dihydro-2-methyl-4-oxo-6-quinazolinyl)methyl)-N-(prop-2-ynyl)aniline,
was selected, on the basis of its
inhibition of both TS and cell growth, for antitumor testing; it gave a
61% increase in life span
to mice bearing the thymidine kinase-deficient L5178Y
(TK-) lymphoma. A crystal structure
of
N-((3,4-dihydro-2-methyl-4-oxo-6-quinazolinyl)methyl)-4-((2-methylphenyl)sulfinyl)-N-(prop-2-ynyl)aniline complexed with E. coli TS was solved and
revealed selective binding of one
sulfoxide enantiomer. AMBER calculations showed that the
enantioselection was due to
asymmetric electrostatic effects at the mouth of the active site.
In contrast, a similar crystal
structure of the sulfoxide 7c, along with AMBER
calculations, indicated that both enantiomers
bound, but with different affinities. The side chain of Phe176
shifted in order to structurally
accommodate the chlorine of the more weakly bound
enantiomer.
Download the full text:
PDF |
HTML

